In our latest IPWatchdog Unleashed podcast, we had a riveting and sometimes emotional conversation that unfolded around one of the most pressing issues in life sciences today: the journey of life-saving drugs from laboratory to patient. We discuss the pivotal role a strong patent system plays in this important journey with guest Sherry Knowles. Sherry is the founder of Knowles Intellectual Property Strategies and former Senior Vice President and Chief Patent Counsel for GlaxoSmithKline. In addition to being one of the leading voices in the life sciences and patent industries, Sherry is also a cancer survivor. Among other things we discuss numerous patent system challenges facing innovator drug companies, the downward pressure generic drugs place on the industry and leading to important drugs becoming unavailable, the role of Pharmacy Benefit Managers (PBMs) with respect to significantly raising the cost of drugs for Americans, and policy influences and legislation on Capitol Hill. Sherry also shares her personal story and insights into why patents are more than just legal constructs—they are deeply personal lifelines.
The post The Personal Side of Patents: The Battle for Life-Saving Drugs | IPWatchdog Unleashed appeared first on IPWatchdog.com | Patents & Intellectual Property Law.
Recent Posts
- The Personal Side of Patents: The Battle for Life-Saving Drugs | IPWatchdog Unleashed
- CAFC Majority Reverses PTAB Obviousness Ruling Over Dissent, But Rule 36 Issues Persist for CPC Patent
- Liability Risks Before the UPC: How U.S. Companies Need to Prepare
- Other Barks & Bites for Friday, November 7: CJEU Action Against EU Commission Referred Over SEP Regulation; Ninth Circuit Affirms CoComelon Copyright Win; and C4IP Urges USTR to Address IP Concerns in USMCA Joint Review
- Mixed UK High Court Ruling Fails to Answer Fundamental Questions of AI Copyright Infringement
